CClinicalTrials.gg
RecruitingNCT05995678SH-SPUpdated Mar 6, 2026

A Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Transitioned Veterans

An interventional study of STEP-Home-SP and Transition Assistance Program in TBI, Suicide Prevention and Veterans, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Risk of Veteran suicide is elevated during the first year of transition from military service to civilian life. Most Veteran suicides occur among Veterans who are not connected to VA healthcare. Suicide prevention and connection to care are therefore critical for recently transitioning Veterans. Transitioning Veterans require services to provide them with suicide prevention education, skills to manage their transition effectively, and support in their access to VA healthcare. Convenient, accessible, palatable, patient-centered care options that are cost-effective, easy to implement nationwide, and target domains known to mitigate suicide risk are needed during this critical transition period. This proposal would bridge this important healthcare gap using STEP-Home-SP, a transdiagnostic, non-stigmatizing, skills-based workshop. STEP-Home-SP will provide Veterans with suicide prevention education, skills to improve transition, support to access VA care, and a platform to decrease social isolation early in their military to civilian transition, thereby reducing suicide risk downstream.

Read the detailed description

Veterans face a "deadly gap" during their first year of transition from military to civilian life with limited available psychiatric services and increased suicide risk factors. During this critical transition period, Veteran suicide rate is double that of active service members and the general Veteran population. An average of 20 Veterans die from suicide each day, but only 6 of the 20 use VA services. VA care engagement has been shown to mitigate suicide risk; therefore, promoting engagement during the "deadly gap" could be essential to suicide prevention. Transitioning Veterans require outreach and services to provide them with support in their access to VA healthcare, suicide prevention education, and skills to manage their transition effectively. This proposal would bridge this important healthcare gap using STEP-Home. STEP-Home is an evidence-based, transdiagnostic, video telehealth rehabilitation workshop to improve reintegration, social support, and functioning among Veterans with high clinical comorbidity. STEP-Home is non-clinical, cost-effective, and skills-focused to maximally engage Veterans not participating in treatment who may be resistant to traditional "mental health" diagnostically focused approaches. To date, STEP-Home has not been adapted for the unique needs of recently transitioning Veterans or augmented for suicide prevention. This proposal will adapt and refine STEP-Home specifically for recently transitioning Veterans and add suicide prevention content and skills to create STEP-Home-SP. The proposed pilot study is designed to support STEP-Home and suicide prevention content experts in their refinement and evaluation of STEP-Home-SP. The investigators will utilize the VA/Department of Defense Identity Repository (VADIR) to recruit recently transitioned Veterans nationwide. In Aim 1, the investigators will develop STEP-Home-SP by adapting the STEP-Home telehealth intervention to specifically target recently transitioned Veterans and augment the workshop to include suicide prevention. In Aim 2, the investigators will conduct a two-arm proof-of-concept acceptability and feasibility randomized controlled trial (RCT) of STEP-Home-SP versus Enhanced Usual Care (EUC=current standard of care + educational packet on suicide risk and connection to VA care) in recently transitioned Veterans. Lastly, the investigators will explore reintegration status, VA care initiation, and candidate outcomes for STEP-Home-SP relative to EUC to inform a future full-scale RCT. If successful, fostering social, vocational, and community connection; building emotion regulation and impulse control skills; facilitating safety planning; and providing education and access to VA care upstream should result in decreased suicide risk during this critical transition and beyond.

02

Conditions studied

  • TBI
  • Suicide Prevention
  • Veterans
  • PTSD
  • Transdiagnostic
  • Anger

Keywords

  • Veterans
  • TBI
  • Transdiagnostic
  • Intervention
  • Suicide Prevention
  • PTSD
  • Reintegration
03

In context

Suicide Prevention

190 studies on the registry are indexed under Suicide Prevention; 87 are open to participants now.

This study's planned enrollment of 120 is below the median of 150 across 169 interventional studies indexed under Suicide Prevention.

Browse Suicide Prevention studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Recently transitioned Veterans within three years of separation from military service
  • Self-reported functional impairment or reintegration difficulties as measured by the Military-to-Civilian Questionnaire (any item score > 1 indicating "some difficulty"; M2CQ; [71])
  • Sufficient English fluency
  • Agree to participate (informed consent/HIPAA)

Exclusion criteria

Exclusion Criteria:

  • Active psychosis
  • Imminent or acute high suicide risk requiring immediate crisis intervention (low-moderate non-imminent risk for suicide is allowed)
  • Current moderate or severe substance use disorder
  • Neurological diagnosis excluding TBI

    • Participants with mild substance use disorder will be allowed
    • Substance use is a common behavior that may contribute to reintegration difficulties and suicide risk
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    STEP-Home-SP + Usual Care

    The core skills of emotional regulation and problem solving are introduced and integrated throughout all Veteran-specific reintegration content modules for practice and repetition for 12 weeks. Attention training augments emotional regulation and problem solving core skills and is interspersed throughout group and individual sessions. Additional 30-minute individual skill building and goal setting sessions occur \~4-6 times based on individual Veteran needs

    Behavioral: STEP-Home-SP · Behavioral: Transition Assistance Program · Behavioral: VA Solid Start

  • Active comparator
    Usual Care

    UC will include the Transition Assistance Program (TAP) as scheduled by DOD prior to military separation, VA Solid Start post-separation, and educational augmentation post-separation.

    Behavioral: Transition Assistance Program · Behavioral: VA Solid Start

Interventions

  • BehavioralSTEP-Home-SP

    This group will meet for \~1.5 hours/week for 12 weeks. The core skills of Emotional Regulation (ER) and Problem Solving (PS) are introduced and then integrated throughout all Veteran-specific content modules for practice and repetition for 12 weeks. Attention training augments ER and PS skills and is interspersed throughout the group and individual sessions. Additional 30-minute individual skills building and goal setting sessions occur up to 6 times based on individual Veteran needs. STEP-Home staff will work in pairs to run workshops per established protocols. Workshops will be conducted via VA approved video telehealth.

  • BehavioralTransition Assistance Program

    Provides training, skills, and information to help transitioning service members and their families prepare for the military to civilian transition. Each service member works with a TAP counselor to identify needs and post transition goals to build an Individual Transition Plan, in addition to TAP core curriculum courses.

    Also known as: TAP

  • BehavioralVA Solid Start

    VA Solid Start includes a series of outreach calls and emails to all Veterans at 90-, 180-, and 365-days post service separation. Callers follow a standard script to describe services available through VA and provide contact information for desired services.

06

What researchers measure

Primary outcomes

  1. Feasibility- recruitment interest

    ratio interested of those approached for the workshop

    Time frame: Through study completion, an average of one year.

  2. Feasibility- enrollment

    Ratio enrolled (consented) of those approached, greater than 20% of those interested enroll in the proposed time frame

    Time frame: Through study completion, an average of one year.

  3. Feasibility- qualitative via Narrative Evaluation of Intervention Interview

    Identification of challenges and facilitators during the recruitment process as assessed by study staff as well as feedback from focus group participants generated using the Narrative Evaluation of Intervention Interview (NEII). This is an interview composed of 16 open ended questions that allows participants to evaluate the process and outcomes of the intervention. Reviewers will generate a list of themes based on the responses to this interview.

    Time frame: Through study completion, an average of 3 months.

  4. Feasibility- Treatment Fidelity/adherence

    Supervisor and therapist Likert rating of adherence to content for core skills and treatment modules, less than 20% deviations on a treatment fidelity scale. Lower scores indicate stronger treatment fidelity, with each question being answered on a scale from 1 (Strongly Agree) to 5 (Strongly Disagree).

    Time frame: Through study completion, an average of 1 week.

  5. Acceptability- Veteran adherence

    Attendance rate for the 12-session workshop

    Time frame: Through study completion, an average of one year.

  6. Acceptability- Quantitative satisfaction via Client satisfaction questionnaire Change

    Client satisfaction questionnaire (CSQ-8), total scores range from 8 to 32 with higher scores indicating higher satisfaction. A priori criteria is that greater than 80% of participants will score greater that a 24 on the CSQ-8.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  7. Reintegration status- Military to Civilian Questionnaire (M2CQ) Change

    16 questions are answered on a scale from 0 (no difficulty) to 4 (extreme difficulty), with lower scores indicating more successful reintegration.

    Time frame: Assessed at screening, baseline (0 weeks), T4 (after 12 weeks) and T5 (after 24 weeks)

Secondary outcomes

  1. Engagement in VA Care

    Electronic medical record data (if available) showing occurrence of one or more healthcare appointments

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

Other outcomes

  1. Difficulties in Emotional Regulation Scale (DERS)

    36 statements are each ranked on the following scale by participants: 1 almost never (0-10%), 2 sometimes (11-35%), 3 about half the time (36-55%), 4 most of the time (66-90%), or 5 almost always (91-100%). This produces scores for 6 subscales: nonacceptance of emotional responses; difficulty engaging in goal-directed behavior; impulse control difficulties; lack of emotional awareness; limited access to emotion regulation strategies; lack of emotional clarity.

    Time frame: Assessed at baseline (0 weeks), T2 (after 4 weeks), T3 (after 8 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  2. Problem Solving Inventory (PSI)

    Participants rank 35 statements on a Likert scale from 1 (strongly agree) to 6 (strongly disagree). This generates a total score and 3 subscale scores for the following categories: Approach Avoidance, Personal Control, and Problem Solving Confidence.

    Time frame: Assessed at baseline (0 weeks), T2 (after 4 weeks), T3 (after 8 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  3. Attention-Related Cognitive Errors Scale (ARCES)

    12 questions are ranked on a Likert Scale from 1 (never) to 5 (very often) with higher scores indicating more frequent attention related cognitive errors.

    Time frame: Assessed at baseline (0 weeks), T2 (after 4 weeks), T3 (after 8 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  4. Suicidal Ideation- The Columbia-Suicide Severity Rating Scale (C-SSRS)

    Participants are asked 5 questions designed to assess severity of suicide risk. Questions are answered yes or no, with endorsement of active suicidal ideation with intent being considered high risk and suicidal ideation without intent considered moderate risk.

    Time frame: Assessed at screening, baseline (0 weeks), T2 (after 4 weeks), T3 (after 8 weeks), T4 (after 12 weeks), and T5 (after 24 weeks). Will also be administered as needed following workshop sessions.

  5. Post-deployment Readjustment Inventory (PDRI)

    36 statements are ranked by participants on a scale from 1 (not at all) to 5 (extremely). Total score is calculated by the sum of each of the subscales: Career, Health, Intimate relationships, social readjustment, concerns about deployment, and PTSD symptoms. Higher scores indicate less successful post-deployment readjustment.

    Time frame: Assessed at screening, baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  6. State-Trait Anger Expression Inventory (STAXI-2)

    Measures the experience, expression, and control of anger. Participants rank each of the statements on a scale of 1 (not at all) to 4 (very much so) for section 1 and 1 (almost never) to 4 (almost always) for sections 2 and 3. Higher scores indicate high experience/expression and low control of anger.

    Time frame: Assessed at screening, baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  7. Functional status measured using the WHO Disability Assessment Schedule 2.0 12-item (WHODAS-2.0)

    Participants indicate how much difficulty they have had in the last 30 days for each of the statements on the assessment on a scale from 0 (none) to 4 (Extreme/cannot do). Higher scores indicate greater levels of disability.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  8. Stigma- Perceived Barriers to Care Survey

    Participants rank each of the survey items on the scale from 1 (strongly agree) to 5 (strongly disagree) with lower scores indicating that the item is a greater barrier to care.

    Time frame: Assessed at baseline (0 weeks), T2 (after 4 weeks), T3 (after 8 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  9. Quality of Life Scale (QOLS)

    Participants answer each question on a 7 point scale. It is scored by adding up the score on each item to get a minimum potential score of 16 and a maximum total score of 112. Higher scores indicate a higher quality of life.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  10. Psychosocial Functioning- The Brief Inventory of Psychosocial Functioning (IPF-Brief)

    Participants rank each of the 7 statements based on their overall experience over the past month on a scale from 0 (not at all) to 6 (very much). 7 is marked if the statement is not applicable. Higher scores indicate more impaired psychosocial functioning.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  11. Social support subscale of the Deployment Risk and Resilience Inventory (DRRI-2)

    Participants rank each of the ten questions from this subscale on a scale from 1 (Strongly Disagree) to 5 (Strongly Agree) and total subscale score is calculated by adding up the responses from each of the questions. Lower scores indicate lower levels of social support.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  12. Interpersonal Needs Questionnaire (INQ)

    Each of the 15 questions are answered on a scale from 1 (Not at all true for me) to 7 (very true for me). 6 out of the 15 questions are reverse coded. Higher scores indicate that more interpersonal needs are not met.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  13. Depression- Patient Health Questionnaire (PHQ-9)

    Participants rank 9 questions on a scale from 0 (not at all) to 3 (Nearly every day) based on how often in the last 2 weeks they have been bothered by the problems listed. Then they rate the severity of the difficulty any problems they have experienced are causing on a scale from "not difficult at all" to "extremely difficult." Higher scores indicate higher depression severity.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  14. Hopelessness- Beck Hopelessness Scale

    Participants answer 20 true or false questions that are scored based on an answer key. Answers that indicate hopelessness are added up, with higher scores indicating higher levels of hopelessness/pessimism.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  15. Self-injurious thoughts and behaviors interview (SITBI)

    This interview asks a wide variety of questions related to suicidal ideations, plans, gestures, attempts, and non-suicidal self injurious behaviors. There are 72 possible questions, but some are only asked if a specific behavior is endorsed. Higher scores indicate higher levels of thoughts and feelings related to suicide and self-injurious behaviors.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  16. Suicide Coping/Safety Behaviors- Suicide Related Coping Scale (SRCS)

    Participants answer 17 questions on a 5 point Likert scale from 0-4 (Strongly Disagree to Strongly Agree). Total score is determined by reverse scoring negatively worded items and then summing the items. Higher scores indicate better coping skills.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  17. Gateway to vocational and community activities- Treatment & Activities Survey

    Treatment \& Activities Survey developed by STEP-Home staff asks participants to list the types of treatment (psychotherapy, medication, group therapy) that they have participated in within the last month, what they receive the treatment for, and whether it is administered by the VA or outside of the VA. Participants also answer if they have participated in other activities in the last month (school, work, community, etc.) and whether those activities are at or outside of the VA.

    Time frame: Assessed at baseline (0 weeks), T4 (after 12 weeks), and T5 (after 24 weeks)

  18. Kessler-6 brief mental health screen

    The Kessler Psychological Distress Scale (K6) is a 6 item measure of participants' emotional state. Questions are scored from 0 (none of the time) to 4 (all of the time) with a minimum score of 0 and a maximum score of 24. Higher scores indicate higher levels of psychological distress.

    Time frame: Baseline (0 weeks)

07

Study locations

1 of 1 sites recruiting
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts 02130-4817, United States
    • Catherine B Fortier, PhD · Contact · catherine.fortier@va.gov · 857-364-4361
    • Catherine B Fortier, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — No additional IPD will be shared besides the deidentified/anonymized data set and data dictionary will be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05995678
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Aug 16, 2023
Start date
Mar 1, 2024
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Mar 6, 2026

Study contacts

Catherine B Fortier, PhD
Contact
catherine.fortier@va.gov
(857) 364-4361
Catherine B Fortier, PhD
principal investigator · VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion